Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.
Sponsor: PDFE Pharma Innovations FZCO
Summary
This study will evaluate the safety and efficacy of PDFE-2304 compared with Minoxidil 5% in men with androgenic alopecia (AGA).
Official title: A Triple-Blind, Randomized, Efficacy and Tolerability Comparison Study of PDFE-2304 Topical Solution Versus Minoxidil 5% Topical Solution for the Treatment of Androgenic Alopecia (AGA).
Key Details
Gender
MALE
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2025-05-14
Completion Date
2025-09-17
Last Updated
2025-06-08
Healthy Volunteers
No
Interventions
Minoxidil 5% Topical Solution
Approximately one mL dose applied onto a pre-specified scalp area twice daily for 16 weeks.
PDFE-2304 Topical Solution
Approximately one mL dose applied onto a pre-specified scalp area twice daily for 16 weeks.
Locations (1)
Koppal Institute of Medical Sciences
Koppal, Karnataka, India